Bayer is transforming its IT function to further accelerate the digitalization of the company. Leading IT providers will take over standardized services, such as the provision of digital workplaces for employees or the global operation of IT infrastructure. Internally, the IT function will focus on differentiating solutions for Bayer's businesses.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Florida-based Health First announced the outcomes of their successful 15-year tele-critical partnership. Powered by Philips' acute telehealth platform eCareManager, Health First's VitalWatch eICU has demonstrated significant reductions in mortality and lengths of stay for the health system's sickest patient population.
At a capital markets event in London, the management of Siemens Healthineers AG will provide further details on the second phase of its "Strategy 2025". This so-called "Upgrading" phase is about taking Siemens Healthineers to the next level of profitable growth.
The U.S. Food and Drug Administration announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device.
| Location: | Home (EU based) |
| Job Type: | Full-Time |
| Employer: | ECHAlliance |
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Paige, a leader in computational pathology, announced a strategic collaboration to deliver clinical-grade AI applications to pathology laboratories. These AI technologies, starting with Paige Prostate, aim to help pathologists identify, quantify and characterize cancer in tissue samples and make precise diagnoses more efficiently.
The medical technology industry welcomes the new European Commission's priority focus on Artificial Intelligence (AI). Our industry sees enormous potential of AI to make healthcare better and safer, improve access and outcomes, empower patients and citizens with information, and make healthcare delivery more efficient.
There are several challenges that impede the deployment of AI in healthcare. These include a fragmented data landscape that makes access to or sharing of data difficult, a lack of interoperability, and a shortage of incentives for data sharing. Legal, technical and social challenges present additional obstacles for the sharing and aggregation of data.
The challenge is to enable public procurers to collectively implement PCPs in order to close the gap between supply and demand for innovative integrated care solutions. The objective is to bring radical improvements to the quality and efficiency of public services and service delivery by encouraging the development and validation of breakthrough solutions through Pre-Commercial Procurement.
As announced on May 14, 2019, the Board of Directors decided to investigate the sale of a part of Agfa HealthCare in the framework of the Agfa-Gevaert Group's transformation process.
Today, the Agfa-Gevaert Group announces that it has entered into exclusive negotiations with Dedalus Holding S.p.A. to sell a part of its HealthCare IT business (the "Business").